Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2000
08/09/2000EP1025089A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
08/09/2000EP1025088A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease
08/09/2000EP0734384B1 3-substituted 1-arylindole compounds
08/09/2000EP0623132B1 Disubstituted polycyclic systems as cognition enhancers
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262272A HIV proteinase inhibitor
08/09/2000CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100399 Synthesis for 4-aryl-5-pyrimidine imidazole substituted compounds
08/08/2000US6100289 Indole derivatives
08/08/2000US6100284 Antiallergens
08/08/2000US6100279 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100277 Retroviral protease inhibitor combinations
08/08/2000US6100276 Cholinergic agents; cognition activators
08/08/2000US6100269 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100258 Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
08/08/2000US6100257 2-haloalkyl,3-(haloalkyl, alkenyl, or alkynyl),5-(substituted phenyl or heterocycle),6-alkyl-pyrimidin-4-one compounds of given structure; use as herbicides
08/08/2000US6100253 Tricycle substituted with azaheterocyclic carboxylic acids
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/08/2000CA2072575C Anticholinergic agents
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/03/2000WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
08/03/2000WO2000044744A1 Potassium salt of ($i(s))-omeprazole
08/03/2000WO2000044743A1 Amide derivatives and drug compositions
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents
08/03/2000WO2000044726A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
08/03/2000WO2000044722A1 Chondrongenesis promotors and indolin-2-one derivatives
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044376A1 Antidepressant heterocyclic compounds
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO2000005208A9 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
08/03/2000DE19904310A1 Verfahren zur Herstellung heterocyclischer Verbindungen Process for the preparation of heterocyclic compounds
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2360683A1 Antidepressant heterocyclic compounds
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/02/2000EP1024140A1 Process for N-alkylation of cyclic cyanoamidines
08/02/2000EP1024138A1 Pyrazole derivatives
08/02/2000EP1023898A1 Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands
08/02/2000EP1023287A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
08/02/2000EP1023286A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023268A1 Isoquinolines as urokinase inhibitors
08/02/2000EP1023265A1 Azetidinone derivatives for the treatment of hcmv infections
08/02/2000EP1023073A1 Vitronectin receptor antagonist
08/02/2000EP1023072A1 Analgesic compositions
08/02/2000EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES
08/02/2000EP1023061A1 Somatostatin agonists
08/02/2000EP0731796B1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
08/02/2000CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261886A Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperdylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine
08/02/2000CN1261885A 2-substituted 4,5-diaryl imidazoles
08/02/2000CN1261883A Novel compounds
08/02/2000CN1261880A Inhibitors of farnesyl protein transferase
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/01/2000US6096895 Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
08/01/2000US6096887 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
08/01/2000US6096886 Morpholino end-capped, hindered amine substituted aminotriazine
08/01/2000US6096772 Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096762 Contacting nerve cells with a neurotrophic amount of difluoroamide compound with affinity for an fk-506 binding protein for stimulating neurite grwoth in nerve cells
08/01/2000US6096761 Esters of 3-hydroxy-piperidinemethanol derivatives
08/01/2000US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096752 Method for the preparation of tertiary amines, a compound useful therefor and alpha-2-receptor active tetrahydroisoquinoline derivatives
08/01/2000US6096751 Substituted 1,2,3,4-tetrahydro-55-nitro-pyrimidines
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096746 Indazole compound containing a monocyclic amine structure
08/01/2000US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives
08/01/2000US6096741 Oxime derivatives, hydrazone derivatives and use thereof
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096736 Benzazepine derivatives with vasopressin agonistic activity
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096689 5-pyrazolylbenzoic acid derivatives as herbicides
08/01/2000CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists
08/01/2000CA2199845C Quinoxalinedione nmda receptor antagonists
08/01/2000CA2133762C Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
07/2000
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043383A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
07/27/2000WO2000043374A1 Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
07/27/2000WO2000043373A2 Kinase inhibitors
1 ... 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 ... 1080